What is Amylyx Pharmaceuticals, Inc.'s total revenue?

Amylyx Pharmaceuticals, Inc. (AMLX) reported total revenue of $0 in Q4 2025.

What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total revenue?

Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $380.79M to $0.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Amylyx Pharmaceuticals, Inc. AMLX Total Revenue

Discontinued — last reported Q4 '25

Total Revenue at other companies

Viking TherapeuticsVKTX

$0—

Beam TherapeuticsBEAM

$31.74M+325%

Crinetics PharmaceuticalsCRNX

$10.73M+2,873%

Agios PharmaceuticalsAGIO

$20.75M+138%

Rhythm Pharmaceuticals, Inc.RYTM

$60.11M+83.8%

Taysha Gene Therapies, Inc.TSHA

$0-100%

Other financials

Income statement

See full

Gross profit-—

Operating income-$43.8M-15.8%

Net income-$41.3M-15.0%

EPS (diluted)-$0.37+11.9%

Balance sheet

See full

Cash & equivalents$229.1M+283%

Total debt$5.6M+307%

Total equity$273.2M+35.6%

Total assets$293.6M+33.7%

Cash flow

See full

Operating cash flow-$36.9M+7.4%

CapEx$86.0K+330%

Free cash flow-$28.0M+52.6%

Valuation

See full

Market cap$1.82B+390%

Enterprise value$1.6B+414%

Profitability

See full

Gross margin100%+6.9pp

Operating margin-47,349.8%-47,409pp

Net margin-45,096.2%-45,152pp

FCF margin-39,826.7%-39,847pp

Returns & leverage

See full

Return on equity-63.3%-12.2pp

Debt / equity0×0.0×

Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s total revenue?: Amylyx Pharmaceuticals, Inc. (AMLX) reported total revenue of $0 in Q4 2025.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total revenue?: Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $380.79M to $0.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.